Evaxion A (EVAX) Return on Sales (2024 - 2026)
Evaxion A's (EVAX) quarterly Return on Sales came in at 0.02% in Q1 2026, up 3.0% YoY from 0.01% in Q1 2025, and down 22.01% on a QoQ basis from 0.01% in Q4 2025.
Evaxion A (EVAX) Return on Sales (2024 - 2026) Analysis & Trends
Evaxion A (EVAX) has 3 years of Return on Sales data on file, last reported at 0.02% in Q1 2026.
- Quarterly Return on Sales rose 3.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (up 3.0% YoY) and the FY2025 annual result came in at 0.01%, up 2.0% from the prior year.
- Return on Sales fell to 0.02% in Q1 2026, from 0.01% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.15% in Q1 2024 to a low of 1.41% in Q2 2025.
- A 3-year average of 0.23% and a median of 0.02% in 2026 frame the typical range for Return on Sales.
- The widest YoY moves for Return on Sales: up 33 bps in 2025, down 100 bps in 2025.
- Tracing EVAX's Return on Sales over 3 years: stood at 0.34% in 2024, then soared by 96 bps to 0.01% in 2025, then declined by 22 bps to 0.02% in 2026.
- The last three Return on Sales figures came in at 0.02% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | -1.41% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | -0.34% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.42% |
| Mar 31, 2024 | 0.15% |